Mesoblast LTD (MEOBF) — 6-K Filings

All 6-K filings from Mesoblast LTD. Browse 50 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (50)

Mesoblast Ltd Files 6-K Report — Dec 30, 2025 Risk: low
On December 30, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This report is filed as a Form 6-K with the SE
6-K Filing — Dec 29, 2025
Mesoblast Ltd Files 6-K on Unquoted Equity Securities — Dec 18, 2025 Risk: low
On December 17, 2025, Mesoblast Limited filed a Form 6-K with the SEC, reporting a new issue announcement to the Australian Securities Exchange. This announceme
Mesoblast Ltd Files 6-K with SEC — Dec 12, 2025 Risk: low
On December 12, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The fili
6-K Filing — Dec 4, 2025
6-K Filing — Nov 26, 2025
6-K Filing — Nov 25, 2025
6-K Filing — Nov 24, 2025
Mesoblast Ltd Files 6-K Report — Nov 17, 2025 Risk: low
On November 17, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month
6-K Filing — Nov 5, 2025
Mesoblast Files Director Interest & New Issue Notices — Oct 29, 2025 Risk: medium
On October 28, 2025, Mesoblast Limited filed a new issue announcement and a change of director's interest notice (Appendix 3Y) with the Australian Securities Ex
Mesoblast Ltd Files Annual Report — Oct 28, 2025 Risk: low
On October 28, 2025, Mesoblast Limited filed its Annual Report to Shareholders with the Australian Securities Exchange. The report is incorporated into this For
Mesoblast Ltd Files Quarterly Report — Oct 22, 2025 Risk: medium
Mesoblast Limited filed a quarterly report (Appendix 4C) with the Australian Securities Exchange on October 20, 2025, for the quarter ended September 30, 2025.
Mesoblast Ltd. Files 6-K for Unquoted Equity Securities — Oct 15, 2025 Risk: medium
On October 15, 2025, Mesoblast Limited filed a Form 6-K with the SEC, reporting a new issue of unquoted equity securities as announced to the Australian Securit
Mesoblast Ltd Files 6-K Report — Oct 7, 2025 Risk: low
On October 7, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month o
Mesoblast Ltd Files 6-K with SEC — Oct 3, 2025 Risk: low
On October 3, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a press release previously announced on the Australian Securities Exchange. This
Mesoblast Ltd Files 6-K with ASX Announcement — Sep 29, 2025 Risk: medium
Mesoblast Limited filed a Form 6-K on September 29, 2025, reporting a new release announcement made on September 26, 2025, to the Australian Securities Exchange
Mesoblast Files New Issue and Director Interest Notices — Sep 15, 2025 Risk: low
On September 12, 2025, Mesoblast Limited filed a new issue announcement and a change of director's interest notice (Appendix 3Y) with the Australian Securities
Mesoblast Ltd Files 6-K Report — Sep 4, 2025 Risk: low
On September 4, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a press release announced on the Australian Securities Exchange. The filing is
Mesoblast Ltd Files 6-K with ASX Announcements — Aug 29, 2025 Risk: low
On August 29, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement and investor presentation. The company, incorporated i
Mesoblast Ltd Files August 2025 6-K Report — Aug 27, 2025 Risk: low
On August 27, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. This filin
Mesoblast Ltd Files Quarterly Report — Jul 18, 2025 Risk: low
On July 18, 2025, Mesoblast Limited filed its Appendix 4C quarterly report for the period ending June 30, 2025. The filing details the company's cash flow activ
Mesoblast Ltd. Files Appendix 3H with ASX — Jul 15, 2025 Risk: low
On July 14, 2025, Mesoblast Limited filed an Appendix 3H with the Australian Securities Exchange, announcing the cessation of securities. This filing is part of
Mesoblast Ltd Files 6-K with SEC — Jul 1, 2025 Risk: low
On July 1, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. This filing i
Mesoblast Ltd Files 6-K with SEC — Jun 12, 2025 Risk: low
On June 12, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The filing d
Mesoblast Ltd Files 6-K Report — May 15, 2025 Risk: low
On May 15, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of M
Mesoblast Ltd Files Quarterly Report — Apr 30, 2025 Risk: medium
On April 30, 2025, Mesoblast Limited filed a quarterly report (Appendix 4C) with the Australian Securities Exchange for the quarter ended March 31, 2025. The co
Mesoblast Ltd Appoints Dr. Fred Hassan to Board — Apr 29, 2025 Risk: low
On April 29, 2025, Mesoblast Limited announced the appointment of a new director, Dr. Fred Hassan, to its Board of Directors. Dr. Hassan brings extensive experi
Mesoblast Ltd Files 6-K with Director Interest Notice — Apr 24, 2025 Risk: low
On April 24, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new issue announcement and a change of director's interest notice (Appendix 3Y)
Mesoblast Ltd Files 6-K with SEC, Incorporates ASX Announcement — Apr 17, 2025 Risk: low
On April 17, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. This filing
Mesoblast Ltd Files Securities Cessation Notice — Apr 15, 2025 Risk: low
On April 14, 2025, Mesoblast Limited filed a notification of cessation of securities (Appendix 3H) with the Australian Securities Exchange. This filing indicate
Mesoblast Files Director Interest Change & New Issue Announcement — Apr 9, 2025 Risk: low
On April 8, 2025, Mesoblast Limited filed a new issue announcement and a change of director's interest notice (Appendix 3Y) with the Australian Securities Excha
Mesoblast Ltd Files 6-K with ASX Announcement — Apr 4, 2025 Risk: low
On April 4, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. This filing
Mesoblast Ltd Files 6-K with SEC — Apr 3, 2025 Risk: low
On April 3, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. This filing
Mesoblast Ltd Files 6-K with SEC — Mar 31, 2025 Risk: low
On March 31, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The filing
Mesoblast Ltd Files 6-K Update — Mar 27, 2025 Risk: low
On March 27, 2025, Mesoblast Limited filed a Form 6-K with the SEC, incorporating by reference a new release announcement made to the Australian Securities Exch
Mesoblast Ltd Files 6-K with SEC — Mar 14, 2025 Risk: low
On March 14, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a press release announcement made to the Australian Securities Exchange. The filin
Mesoblast Ltd Files 6-K with SEC — Mar 13, 2025 Risk: low
On March 13, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The filing
Mesoblast Ltd Files 6-K with SEC — Mar 12, 2025 Risk: low
On March 12, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The filing
Mesoblast Ltd Files March 2025 6-K Report — Mar 7, 2025 Risk: low
On March 6, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of
Mesoblast Ltd Files 6-K with ASX Updates — Feb 28, 2025 Risk: low
On February 27, 2025, Mesoblast Limited filed a new release announcement and an investor presentation with the Australian Securities Exchange. This filing is a
Mesoblast Ltd. Files 6-K with Financial Updates — Feb 27, 2025 Risk: low
Mesoblast Ltd. filed a 6-K report for the period ending December 31, 2024. The filing includes financial data for the six months ended December 31, 2024, and co
Mesoblast Ltd. Files 6-K with ASX Announcement — Feb 25, 2025 Risk: low
On February 24, 2025, Mesoblast Limited announced a new release filed with the Australian Securities Exchange. The company is incorporated in Australia and its
Mesoblast Ltd Files 6-K with SEC — Feb 14, 2025 Risk: low
On February 14, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The fili
Mesoblast Ltd Files Quarterly Report — Jan 31, 2025 Risk: low
On January 31, 2025, Mesoblast Limited filed a quarterly Appendix 4C report with the Australian Securities Exchange. This report covers the period ending Januar
Mesoblast Ltd Announces New Securities Issue — Jan 24, 2025 Risk: medium
On January 17, 2025, Mesoblast Limited announced a new securities issue and applied for quotation of these securities on the Australian Securities Exchange. Thi
Mesoblast Raises AUD 100M for Remestemcel-L — Jan 16, 2025 Risk: medium
On January 14, 2025, Mesoblast Limited announced the completion of a placement of new ordinary shares, raising approximately AUD 100 million. The placement was
Mesoblast Ltd Announces New Share Issuance — Dec 23, 2024 Risk: medium
On December 20, 2024, Mesoblast Limited announced a new share issuance and filed change of directors' interest notices (Appendix 3Y) with the Australian Securit
Mesoblast Ltd Files 6-K Report — Dec 20, 2024 Risk: low
On December 18, 2024, Mesoblast Limited announced a new release filed with the Australian Securities Exchange. This filing is a Form 6-K report for the month of
Mesoblast Ltd Files December 2024 Update — Dec 9, 2024 Risk: low
Mesoblast Limited announced on December 5, 2024, that it filed a new release with the Australian Securities Exchange. This filing is an update for the month of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX